NR4A1 and breast carcinoma: This study aimed to evaluate TILs in breast carcinoma tissues by analyzing CD3 expression through immunohistochemistry (IHC) and examining its association with various prognostic factors, such as histological grade, clinical stage, lymph node status, and hormone receptor status.